Kliininen tutkimuskeskus
Clinical Research Center

Julkaisut 2008
Publications 2008

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aho L et al. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
2 Bertram L et al. No association between CALHM1 and Alzheimers's disease risk.
3 Blom ES et al. Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.
4 Elovaara I et al. Immunologinen lääkehoito MS-taudin eri vaiheissa.
5 Eskelinen MH et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study.
6 Goldstein LB et al. Relative effects of statin therapy on stroke and cardiovascular events in men and women. Secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study.
7 Helisalmi S et al. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
8 Helisalmi S et al. Genetic study between SIRT1, PPARD, PGC-1alfa genes and Alzheimer's disease.
9 Herukka S-K et al. CSF Abeeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.
10 Hämäläinen A et al. Apolipoprotein E epsilon4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
11 Jauhiainen AM et al. Differential hypometabolism patterns according to mild cognitive impairment subtypes.
12 Jukarainen NM et al. Quantification of 1H NMR spectra of human cerebrospinal fluid: a protocol based on constrained total-line-shape analysis.
13 Julkunen P et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
14 Karjalainen J et al. Dual-frequency ultrasound technique minimizes errors induced by soft tissue in ultrasound bone densitometry.
15 Kivipelto M et al. Apolipoprotein E epsilon4 magnifiles lifestyle risks for dementia: a population-based study.
16 Koivunen J et al. PET amyloid ligand (11C)PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment.
17 Kovacs GG et al. Mixed brain pathologies in dementia: the BrainNet Europe consortium experience.
18 Kärkkäinen M et al. Association between functional capacity tests and fractures: an eight-year prospective population-based cohort study .
19 Lane R et al. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
20 Leinonen V et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11- labeled Pittsburgh compound B.
21 Lämsä R et al. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease.
22 Mäkinen S et al. Coaccumulation of calcium and b-amyloid in the thalamus after transient middle cerebral artery occlusion in rats.
23 Ojala JO et al. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.
24 Parkkinen L et al. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.
25 Peurala SH et al. Restoration of normal cortical excitability and gait ability in acute stroke after intensive rehabilitation.
26 Sirola J et al. Grip strength may facilitate fracture prediction in perimenopausal women with normal BMD: a 15-year population-based study.
27 Sivenius J. TIA- ja aivoinfarktipotilaan antitromboottinen lääkehoito.
28 Soininen H, Hänninen T. Dementoivat sairaudet ja kognitiivinen prosessointi.
29 Suhonen J et al. Hyvät hoitokäytännöt etenevien muistisairauksien kaikissa vaiheissa.
30 Tarkka IM et al. Alterations in cortical excitability in chronic stroke after constraint-induced movement therapy.
31 The European Stroke Organisation (ESO), Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.
32 Tiihonen J et al. Brain anatomy of persistent violent offenders: more rather than less.
33 Vepsäläinen S et al. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
34 Visser PJ et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease.
35 Zhao CS et al. CNS-active drugs in aging population at high risk of cerebrovascular events: Evidence from preclinical and clinical studies.

Kliininen tutkimuskeskus Clinical Research Center
Julkaisutietokanta 27.8.2009 Publications Data Base 27.8.2009